# A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

Source: https://onco.cc/trials/nct06384807/  
OnCo record `nct06384807` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of Cemiplimab in advanced solid tumours, run by Biohaven Therapeutics Ltd., now recruiting.

## Summary

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors. ClinicalTrials.gov record last updated 2026-09-28: recruiting. Enrollment is planned at 500 participants. Primary completion is estimated at 2028-02. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications. Registered interventions: BHV-1510, Cemiplimab, BHV-1510, BHV-1510, Cemiplimab. Registered primary measures: Phase 1: Number of patients with adverse events (AEs); Phase 1: Recommended doses or schedules for expansion (RDEs) and maximum tolerated dose (MTD); Phase 2: Objective Response Rate (ORR) for BHV-1510 for monotherapy and in combination with cemiplimab.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-06
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06384807
- Phase: 1/2
- Setting: A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
- Sponsor: Biohaven Therapeutics Ltd.
- Enrolled: 500

## Notes

- ClinicalTrials.gov record last updated 2026-09-28: recruiting. Enrollment is planned at 500 participants. Primary completion is estimated at 2028-02. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Sources

- ClinicalTrials.gov NCT06384807: https://clinicaltrials.gov/study/NCT06384807

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- targets: [TROP2](https://onco.cc/targets/trop2/)
- drugs: [BHV-1510](https://onco.cc/drugs/bhv-1510/), [Cemiplimab](https://onco.cc/drugs/cemiplimab/)

---
JSON: https://onco.cc/api/v1/entities/nct06384807.json